Development · 27 Aug 2026
2 publishers have reported this development. Each act of reporting is below, cited.
Honasa Consumer has called off its proposed acquisition of a 58 per cent stake in nutraceuticals company Fluence Pharma, citing non-fulfilment of closing conditions under the share purchase agreement.
Honasa Consumer called off its proposed acquisition of a 58% stake in Fluence Pharma after the closing conditions under the share purchase agreement were not fulfilled.
This page is the corroborated record of one development: what each credible source reported, linked and dated. We compile and cite; we do not opine.
fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.